Abbott announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new FreeStyle Lite blood glucose test strips. The new FreeStyle Lite test strips minimize interference during blood glucose testing and are designed to offer a better testing experience, meaning they will ensure faster blood application and reduce the number of error messages and wasted test strips.
The new FreeStyle Lite test strips do not use the GDH-PQQ enzyme, which can be affected by common non-glucose sugars, but instead uses a GDH-FAD enzyme which is unaffected by common non-glucose sugars, such as maltose or galactose, and minimizes the potential for other interference.
According to the manufacturer the new test strips are compatible with all FreeStyle Lite blood glucose monitoring systems and will be available by the end of August 2010.
